
Jared Barsky
Examiner (ID: 7259, Phone: (571)272-2795 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628 |
| Total Applications | 1117 |
| Issued Applications | 492 |
| Pending Applications | 146 |
| Abandoned Applications | 503 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8183966
[patent_doc_number] => 20120114588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/116422
[patent_app_country] => US
[patent_app_date] => 2011-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24317
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114588.pdf
[firstpage_image] =>[orig_patent_app_number] => 13116422
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/116422 | IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS | May 25, 2011 | Abandoned |
Array
(
[id] => 8977383
[patent_doc_number] => 20130210813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'Male Contraceptive Compositions and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/698006
[patent_app_country] => US
[patent_app_date] => 2011-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 24711
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/698006 | Male contraceptive compositions and methods of use | May 15, 2011 | Issued |
Array
(
[id] => 9068126
[patent_doc_number] => 20130259882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'Conjugate of Folate and Antibody Preparation Method and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/884265
[patent_app_country] => US
[patent_app_date] => 2011-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9168
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884265
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884265 | Conjugate of Folate and Antibody Preparation Method and Use Thereof | May 13, 2011 | Abandoned |
Array
(
[id] => 8660149
[patent_doc_number] => 20130040978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/641767
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53059
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641767
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641767 | SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS | May 12, 2011 | Abandoned |
Array
(
[id] => 8822240
[patent_doc_number] => 20130123285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'Compositions and Methods for Targeting A3G:RNA Complexes'
[patent_app_type] => utility
[patent_app_number] => 13/697932
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18165
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/697932 | Compositions and Methods for Targeting A3G:RNA Complexes | May 12, 2011 | Abandoned |
Array
(
[id] => 8830133
[patent_doc_number] => 20130131178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'USE OF OXALOACETATE IN THE TREATMENT OF ISCHAEMIA'
[patent_app_type] => utility
[patent_app_number] => 13/699590
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4249
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699590
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699590 | USE OF OXALOACETATE IN THE TREATMENT OF ISCHAEMIA | May 12, 2011 | Abandoned |
Array
(
[id] => 9603520
[patent_doc_number] => 20140200203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'TOPICAL PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/699333
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6346
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699333
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/699333 | TOPICAL PHARMACEUTICAL COMPOSITIONS | May 12, 2011 | Abandoned |
Array
(
[id] => 8359570
[patent_doc_number] => 20120214734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'TREATMENT OF METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/106608
[patent_app_country] => US
[patent_app_date] => 2011-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8612
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13106608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/106608 | TREATMENT OF METABOLIC DISORDERS | May 11, 2011 | Abandoned |
Array
(
[id] => 9869314
[patent_doc_number] => 08957086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-17
[patent_title] => 'Compounds and methods of treating brain disorders'
[patent_app_type] => utility
[patent_app_number] => 13/695731
[patent_app_country] => US
[patent_app_date] => 2011-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 19438
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695731
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/695731 | Compounds and methods of treating brain disorders | May 3, 2011 | Issued |
Array
(
[id] => 8660138
[patent_doc_number] => 20130040967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => '4\'-DEMETHYLEPIPODOPHYLLOTOXIN DERIVATIVE, PREPARATION METHOD AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/641114
[patent_app_country] => US
[patent_app_date] => 2011-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6123
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641114
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641114 | 4′-demethylepipodophyllotoxin derivative, preparation method and use thereof | Apr 21, 2011 | Issued |
Array
(
[id] => 8638217
[patent_doc_number] => 20130030019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'NOVEL PROLYLCARBOXYPEPTIDASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/638991
[patent_app_country] => US
[patent_app_date] => 2011-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24341
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638991
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/638991 | Prolylcarboxypeptidase inhibitors | Apr 20, 2011 | Issued |
Array
(
[id] => 8660172
[patent_doc_number] => 20130041001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'VALSARTAN DERIVATIVES CARRYING NITROGEN OXIDE DONORS FOR THE TREATMENT OF VASCULAR AND METABOLIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/641747
[patent_app_country] => US
[patent_app_date] => 2011-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6742
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641747
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641747 | Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases | Apr 17, 2011 | Issued |
Array
(
[id] => 8660141
[patent_doc_number] => 20130040969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'Fungicidal Mixtures Based on Azolopyrimmidinylamines'
[patent_app_type] => utility
[patent_app_number] => 13/641754
[patent_app_country] => US
[patent_app_date] => 2011-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48067
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641754
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641754 | Fungicidal Mixtures Based on Azolopyrimmidinylamines | Apr 17, 2011 | Abandoned |
Array
(
[id] => 8829997
[patent_doc_number] => 20130131043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'PYRAZOLE COMPOUNDS AS JAK INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/642189
[patent_app_country] => US
[patent_app_date] => 2011-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21949
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642189
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/642189 | PYRAZOLE COMPOUNDS AS JAK INHIBITORS | Apr 17, 2011 | Abandoned |
Array
(
[id] => 8649627
[patent_doc_number] => 20130035357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'Compositions and Methods for Preventing Joint Destruction in Osteoarthritis'
[patent_app_type] => utility
[patent_app_number] => 13/641173
[patent_app_country] => US
[patent_app_date] => 2011-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3992
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641173
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641173 | Compositions and Methods for Preventing Joint Destruction in Osteoarthritis | Apr 12, 2011 | Abandoned |
Array
(
[id] => 8290396
[patent_doc_number] => 20120178725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'METHOD OF MODULATING SHIP ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/085824
[patent_app_country] => US
[patent_app_date] => 2011-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 14148
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13085824
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/085824 | Method of modulating ship activity | Apr 12, 2011 | Issued |
Array
(
[id] => 7561882
[patent_doc_number] => 20110275715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'METHOD FOR TREATING RETINAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/084927
[patent_app_country] => US
[patent_app_date] => 2011-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23964
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275715.pdf
[firstpage_image] =>[orig_patent_app_number] => 13084927
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/084927 | METHOD FOR TREATING RETINAL DISEASE | Apr 11, 2011 | Abandoned |
Array
(
[id] => 8638173
[patent_doc_number] => 20130029976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'PEST CONTROLLING COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/641420
[patent_app_country] => US
[patent_app_date] => 2011-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4822
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641420
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641420 | PEST CONTROLLING COMPOSITION | Apr 10, 2011 | Abandoned |
Array
(
[id] => 11790181
[patent_doc_number] => 09399756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-26
[patent_title] => 'Functionalized fullerenes as a biomass stimulant and a life extension agent'
[patent_app_type] => utility
[patent_app_number] => 13/638054
[patent_app_country] => US
[patent_app_date] => 2011-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 4761
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638054
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/638054 | Functionalized fullerenes as a biomass stimulant and a life extension agent | Apr 6, 2011 | Issued |
Array
(
[id] => 8909489
[patent_doc_number] => 08481553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-09
[patent_title] => 'Antimetastatic compounds'
[patent_app_type] => utility
[patent_app_number] => 13/639397
[patent_app_country] => US
[patent_app_date] => 2011-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14439
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639397
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/639397 | Antimetastatic compounds | Apr 5, 2011 | Issued |